Disglucemia asociada a fluoroquinolonas: una revisión estructurada.

Autores/as

  • Johan Granados Grupo de Investigación Promoción y Prevención Farmacéutica, Departamento de Farmacia, Universidad de Antioquia Grupo Investigación Clínica HPTU. Hospital Pablo Tobón Uribe
  • Javier Mauricio Ceballos Grupo de Investigación Promoción y Prevención Farmacéutica, Universidad de Antioquia Departamento de Farmacia, Universidad de Antioquia.
  • Pedro Amariles Grupo de Investigación Promoción y Prevención Farmacéutica, Universidad de Antioquia Departamento de Farmacia, Universidad de Antioquia.

Palabras clave:

Hyperglycemia, Hypoglycemia, Quinolones

Resumen

Fluoroquinolone type antimicrobials can cause hypo or hyperglycemia in certain patients. We performed a structured review about this side effect, searching articles published in English or Spanish with full text access in PubMed/Medline. The following MESH terms were used: Hypoglycemia, Hyperglycemia, Quinolones, Ciprofloxacin, Levofloxacin, Moxifloxacin. Additionally, we evaluated the clinical relevance of potential drug interactions, based on the probability of occurrence and the severity of the interaction effect. We obtained 42 publications about the issue; 22 references were selected, where the severity of the interaction in patients with risk factors was evaluated. Patients receiving antidiabetic medications and with risk factors such as advanced age and renal failure may be more likely to have a severe hypoglycemia. In these patients, this drug interaction should be considered clinically relevant since its risk is high or very high.

Descargas

Publicado

2018-05-03

Cómo citar

Granados, J., Ceballos, J. M., & Amariles, P. (2018). Disglucemia asociada a fluoroquinolonas: una revisión estructurada. Revista Médica De Chile, 146(5). Recuperado a partir de https://revistamedicadechile.cl/index.php/rmedica/article/view/6181

Número

Sección

Artículos de revisión